✦ LIBER ✦

Adjuvant Chemotherapy with Doxorubicin and Dacarbazine has No Effect in Recurrence-Free Survival of Malignant Phyllodes Tumors of the Breast

✍ Scribed by Flavia Morales-Vásquez; Ana Maria Gonzalez-Angulo; Kristine Broglio; Horacio N. Lopez-Basave; Dolores Gallardo; Gabriel N. Hortobagyi; Jaime G. De La Garza

Book ID: 109079599
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 107 KB
Volume: 13
Category: Article
ISSN: 1075-122X
DOI: 10.1111/j.1524-4741.2007.00510.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of body mass index on overall

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

✍ Evandro de Azambuja; Worta McCaskill-Stevens; Prudence Francis; Emmanuel Quinaux 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 307 KB

The effect of body mass index (BMI) on d

The effect of body mass index (BMI) on disease-free and overall survival in node-positive breast cancer treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

✍ E. De Azambuja; W. McCaskill-Stevens; E. Quinaux; M. Buyse; J. Crown; P. Francis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Doxorubicin and cyclophosphamide adjuvan

Doxorubicin and cyclophosphamide adjuvant chemotherapy is no more effective than cyclophosphamide, methotrexate, and 5-fluorouracil for premenopausal axillary lymph node positive breast cancer: There is no clear evidence that HER-2 status affects the relative effects of doxorubicin and cyclophosphamide vs cyclophosphamide, methotrexate and 5-fluorouracil in women with operable breast cancer

✍ Dino Amadori 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 346 KB